Cybin (HELP) Intangibles (2021 - 2025)
Cybin (HELP) reported Intangibles of $28.6 million for Q1 2025, up 8.61% on a YoY basis from $26.3 million in Q1 2024, and up 8.93% quarter-over-quarter from $26.2 million in Q4 2024.
Cybin (HELP) Intangibles (2021 - 2025) Analysis & Trends
Cybin has reported Intangibles for 5 years, with the latest figure at $28.6 million in Q1 2025.
- For the quarter ending Q1 2025, Intangibles rose 8.61% year-over-year to $28.6 million; the trailing twelve-month figure through Mar 2025 stood at $28.6 million (up 8.61% YoY), and the FY2025 full-year result was $29.5 million, up 12.11% from the prior year.
- Intangibles for Q1 2025 stood at $28.6 million, up from $26.2 million in the prior quarter.
- The five-year high for Intangibles was $32.5 million in Q4 2023, with the low at $1.3 million in Q1 2021.
- Historically, Intangibles has averaged $13.4 million across 5 years, with a median of $4.2 million in 2023.
- Annual changes were most pronounced in 2023 — Intangibles soared 736.97% — and 2024, when it retreated 19.26%.
- Cybin's Intangibles stood at $1.6 million in 2021, then soared by 143.16% to $3.9 million in 2022, then surged by 736.97% to $32.5 million in 2023, then dropped by 19.26% to $26.2 million in 2024, then rose by 8.93% to $28.6 million in 2025.
- The last three Intangibles figures came in at $28.6 million (Q1 2025), $26.2 million (Q4 2024), and $26.3 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 28.59 Mn |
| Dec 31, 2024 | 26.24 Mn |
| Sep 30, 2024 | 26.34 Mn |
| Jun 30, 2024 | 26.12 Mn |
| Mar 31, 2024 | 26.32 Mn |
| Dec 31, 2023 | 32.50 Mn |
| Sep 30, 2023 | 4.31 Mn |
| Jun 30, 2023 | 4.02 Mn |
| Dec 31, 2022 | 3.88 Mn |
| Sep 30, 2022 | 3.94 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | 1.49 Mn |
| Jun 30, 2021 | 1.42 Mn |
| Mar 31, 2021 | 1.27 Mn |